Updated Jul 16, 2026
Piekos Brian has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $105K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-11 | KALV | KalVista Pharmaceuticals, Inc. | D — Derivative transaction | 21.7K | $0.00 | |
| 2026-05-26 | KALV | KalVista Pharmaceuticals, Inc. | S — Open-market sale | 1.5K | $26.78 | $40K |
| 2026-05-26 | KALV | KalVista Pharmaceuticals, Inc. | M — Option exercise | 5.0K | — | |
| 2026-04-20 | KALV | KalVista Pharmaceuticals, Inc. | S — Open-market sale | 1.9K | $20.22 | $38K |
| 2026-04-20 | KALV | KalVista Pharmaceuticals, Inc. | M — Option exercise | 6.2K | — | |
| 2026-02-25 | KALV | KalVista Pharmaceuticals, Inc. | S — Open-market sale | 1.8K | $15.57 | $28K |
| 2026-02-25 | KALV | KalVista Pharmaceuticals, Inc. | M — Option exercise | 5.0K | — |
Piekos Brian is a corporate insider — currently tracked as Insider of KalVista Pharmaceuticals, Inc. (KALV). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($105K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Piekos Brian profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.